SAMSUNG PHARM. Co., LTD. (KRX:001360)
1,310.00
-72.00 (-5.21%)
Sep 18, 2026, 3:30 PM KST
SAMSUNG PHARM. Co., LTD. Market Cap
SAMSUNG PHARM. Co., LTD. has a market cap or net worth of 123.3 billion as of September 18, 2026. Its market cap has decreased by -23.21% in one year.
Market Cap
123.30B
Enterprise Value
n/a
Revenue
44.29B
Ranking
n/a
PE Ratio
9.70
Stock Price
1,310.00
ChartMarket Cap Chart
Since August 31, 1995, SAMSUNG PHARM. Co., LTD.'s market cap has increased from 17.88B to 123.30B, an increase of 589.40%. That is a compound annual growth rate of 6.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 123.30B | -14.38% |
| Dec 30, 2025 | 144.00B | -0.52% |
| Dec 30, 2024 | 144.76B | -0.84% |
| Dec 28, 2023 | 145.99B | -18.99% |
| Dec 29, 2022 | 180.22B | -45.48% |
| Dec 30, 2021 | 330.57B | -11.17% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| FutureChem Co.,Ltd | 164.94B |
| Daihan Pharmaceutical | 155.23B |
| Ilsung Is | 153.32B |
| Hana Pharm | 146.63B |
| Jeil Pharmaceutical Co.,Ltd | 145.13B |
| Ilyang Pharmaceutical Co.,Ltd | 141.25B |
| Dongwha Pharm.Co.,Ltd | 139.70B |
| Kyongbo Pharmaceutical | 129.34B |